You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CHOP

Showing 26 - 50 of 1,184
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PI3Kd Inhibitor, Parsaclisib, CHOP Trial (Parsaclisib, CHOP)

Not yet recruiting
  • PI3Kδ Inhibitor
  • +3 more
  • (no location specified)
Feb 10, 2022

Diffuse Large B-cell Lymphoma(DLBCL) Trial in Shanghai (Zanubrutinib + R-CHOP)

Recruiting
  • Diffuse Large B-cell Lymphoma(DLBCL)
  • Zanubrutinib + R-CHOP
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 10, 2022

Diffuse Large B Cell Lymphoma Trial (Rituximab, Cyclophosphamide, Doxorubicin)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Apr 24, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Durvalumab, Rituximab, Doxorubicin)

Completed
Has Results
  • Lymphoma, Large B-Cell, Diffuse
  • Gilbert, Arizona
  • +18 more
Aug 19, 2022

B-cell Non Hodgkin's Lymphoma Trial in Beijing (HLX01, Rituximab, CHOP)

Completed
  • B-cell Non Hodgkin's Lymphoma
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

T-cell Lymphoma Trial (Tucidinostat, Azacitidine combined with CHOP)

Not yet recruiting
  • T-cell Lymphoma
  • Tucidinostat, Azacitidine combined with CHOP
  • (no location specified)
Oct 9, 2021

Diffuse Large B Cell Lymphoma Trial in Wenzhou (Zanubrutinib+Rituximab+Lenalidomide, RCHOP/RCDOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Jun 20, 2022

Behavior Disorders Trial in Philadelphia (Coaches with Children's Hospital of Philadelphia (CHOP) Research Consultant Support,

Enrolling by invitation
  • Behavior Disorders
  • Coaches with Children's Hospital of Philadelphia (CHOP) Research Consultant Support
  • Coaches without CHOP Research Consultant Support
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Oct 3, 2022

Mantle Cell Lymphoma Trial in Canada (Acalabrutinib, R-CHOP chemo)

Recruiting
  • Mantle Cell Lymphoma
  • Vancouver, British Columbia, Canada
  • +3 more
Mar 17, 2022

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

Recruiting Trial in Linyi (H02+CHOP, Rituxan +CHOP)

Recruiting
  • Recruiting
  • Linyi, Shandong, China
    Shandong New Time Pharmaceutical Co., LTD
Sep 7, 2021

Diffuse Large B Cell Lymphoma Trial in Busan (PrednisoLONE 50 MG)

Completed
  • Diffuse Large B Cell Lymphoma
  • PrednisoLONE 50 MG
  • Busan, Sue-gu, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 13, 2022

Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

Not yet recruiting
  • Marginal Zone Lymphoma
  • Mosunetuzumab + Lenalidomide
  • +3 more
  • (no location specified)
Aug 16, 2023

Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib plus RCHOP
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 16, 2023

Advanced DLBCL, Extra-nodal Involvement, Large Mass, Radiotherapy Trial (6-8 cycles (21 days per cycle) of Standard R-CHOP

Not yet recruiting
  • Advanced Diffuse Large B-Cell Lymphoma
  • +2 more
  • 6-8 cycles (21 days per cycle) of Standard R-CHOP chemotherapy
  • Radiotherapy beyond standard R-CHOP Chemotherapy
  • (no location specified)
May 24, 2023

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb Trial in Guangzhou (Toripalimab,

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • Toripalimab, Rituximab
  • R-CHOP Protocol
  • Guangzhou, Guangdong, China
    Department of hematology department, Nanfang hospital
Apr 6, 2022

Primary Extranodal Lymphoma, DLBCL Trial (Camrelizumab)

Not yet recruiting
  • Primary Extranodal Lymphoma
  • DLBCL
  • (no location specified)
Apr 6, 2022

Mantle Cell Lymphoma Trial in Birmingham (Ublituximab, Umbralisib)

Recruiting
  • Mantle Cell Lymphoma
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 8, 2021

T Cell Lymphoma Trial in Seoul (ACHOP)

Not yet recruiting
  • T Cell Lymphoma
  • Seoul, Korea, Republic of
    81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
Apr 18, 2022

DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)

Recruiting
  • DLBCL Germinal Center B-Cell Type
  • Guangzhou, Guangdong, China
  • +5 more
Aug 16, 2022

African American Caregivers and Parents and Research Study Registries Trial in Philadelphia (Video, Survey)

Completed
  • African American Caregivers and Parents and Research Study Registries
  • Video
  • Survey
  • Philadelphia, Pennsylvania
    CHOP Primary Care, Cobbs Creek
Nov 14, 2023

Diffuse Large B Cell Lymphoma Trial in Rouen (Measure of the circulating tumor DNA)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Measure of the circulating tumor DNA
  • Rouen, France
    Centre Henri Becquerel
Nov 17, 2023

Diffuse Large B Cell Lymphoma Trial in Colchester, Canterbury, Nottingham (R-CHOP, R-CHOP + acalabrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Colchester, Essex, United Kingdom
  • +32 more
Oct 25, 2022

DLBCL Trial (Sintilimab, Rituximab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • (no location specified)
Mar 6, 2022